Hidradenitis Suppurativa
📧 Sign up to get email alerts when something new happens for Hidradenitis Suppurativa.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS withdrawal · 2025-12-16Clinical Trial Update: Botulinum Toxin-A for Hidradenitis Suppurativa [Phase 4]
A Phase 4 clinical trial of botulinum toxin A for hidradenitis suppurativa has been withdrawn.
-
CLINICAL_TRIALS research · 2025-12-15Clinical Trial Update: An Open-label, Single-arm Study to Evaluate Pharmacokinetics and Safety of Subcutaneous Sonelokimab in Adolescents With Moderate to Severe Hidradenitis Suppurativa (VELA-TEEN) [Phase 3]
An open-label, single-arm Phase 3 study to evaluate pharmacokinetics and safety of subcutaneous sonelokimab in adolescents with moderate to …
-
CLINICAL_TRIALS research · 2025-12-12Clinical Trial Update: Nd:YAG vs Alexandrite Laser Treatment in Hidradenitis Suppurativa [NA]
A clinical trial comparing Nd:YAG laser versus Alexandrite laser treatment for hidradenitis suppurativa; the study status is not yet recruit…
-
EMA approval · 2025-12-11EMA Authorised: Hyrimoz (adalimumab) — Sandoz GmbH
EMA authorised Hyrimoz (adalimumab) by Sandoz GmbH as a biosimilar to Humira for multiple inflammatory diseases, including rheumatoid arthri…
-
CLINICAL_TRIALS trial_result · 2025-12-11Clinical Trial Update: Tofacitinib for Immune Skin Conditions in Down Syndrome [Phase 2]
A Phase 2 trial evaluating tofacitinib for immune-mediated skin conditions in individuals with Down syndrome has completed, with results pos…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2025-12-11Clinical Trial Update: A Phase 2 Study to Evaluate the Efficacy and Safety of SAR444656 Compared With Placebo in Adult Participants With Moderate to Severe Hidradenitis Suppurativa [Phase 2]
Phase 2 study evaluating SAR444656 versus placebo in adults with moderate-to-severe hidradenitis suppurativa was terminated. The document re…
-
CLINICAL_TRIALS trial_result · 2025-12-11Clinical Trial Update: Molecular Evaluation of TAAR1 and JAK/STAT Pathway in Hidradenitis Suppurativa
A completed clinical trial assessing molecular markers related to TAAR1 and the JAK/STAT pathway in hidradenitis suppurativa and related ski…
-
CLINICAL_TRIALS research · 2025-12-03Clinical Trial Update: Comparison of the Clinical Efficacy and Safety of Topical and Subcutaneous Injection of Secukinumab in HS [Phase 4]
This clinical trial update describes a Phase 4 study comparing topical versus subcutaneous secukinumab for hidradenitis suppurativa, current…
-
CLINICAL_TRIALS trial_result · 2025-11-26Clinical Trial Update: Hidradenitis Suppurativa Mail Survey
This document reports the completion of a mail survey conducted as part of a Wake Forest University Health Sciences-sponsored clinical trial…
-
CLINICAL_TRIALS research · 2025-11-24Clinical Trial Update: A 16-Week Study to Learn About the Study Medicine Called Ritlecitinib in Adults With Long Lasting Painful Red Skin Lumps, Known by the Medical Term, Hidradenitis Suppurativa, or HS. [Phase 2]
Phase 2 trial evaluating the study medicine Ritlecitinib in adults with hidradenitis suppurativa is currently recruiting.
-
CLINICAL_TRIALS research · 2025-11-24Clinical Trial Update: Efficacy and Safety of SCT650C in Participants With Moderate to Severe Hidradenitis Suppurativa [Phase 2]
A Phase 2 clinical trial update evaluating the efficacy and safety of SCT650C for moderate to severe hidradenitis suppurativa, with the stud…
-
CLINICAL_TRIALS trial_result · 2025-11-05Clinical Trial Update: Lunsayil 1: A Study to Test Whether Spesolimab Helps People With a Skin Disease Called Hidradenitis Suppurativa [Phase 2, Phase 3]
A Phase 2/3 study (Lunsayil 1) evaluating spesolimab for hidradenitis suppurativa has completed and results have been posted.
-
EMA approval · 2025-10-22EMA Authorised: Amsparity (adalimumab) — Pfizer Europe MA EEIG
EMA authorised Amsparity (adalimumab) from Pfizer Europe MA EEIG. The biosimilar is approved for multiple autoimmune indications including r…
-
EMA approval · 2025-10-21EMA Authorised: Idacio (adalimumab) — Fresenius Kabi Deutschland GmbH
EMA authorised Idacio, a biosimilar of adalimumab, for multiple inflammatory diseases, produced by Fresenius Kabi Deutschland GmbH. The indi…
-
FDA approval · 2025-10-17FDA Approved: HADLIMA — Supplemental Application (Organon LLC)
FDA approved a supplemental application for HADLIMA (adalimumab-bwwd) from Organon LLC, supporting expanded indications for this adalimumab …
-
FDA approval · 2025-10-16FDA Approved: AMJEVITA — Supplemental Application (Nuvaila Limited)
FDA approved a supplemental application for Amjevita (adalimumab-atto) submitted by Nuvaila Limited.
-
CLINICAL_TRIALS research · 2025-10-16Clinical Trial Update: A Study of Eltrekibart (LY3041658) in Adult Participants With Moderate to Severe Hidradenitis Suppurativa [Phase 2]
Phase 2 study of Eltrekibart (LY3041658) in adults with moderate to severe hidradenitis suppurativa. The trial is currently active but not r…
-
CLINICAL_TRIALS trial_result · 2025-10-15Clinical Trial Update: Hidradenitis Suppurativa Study of Izokibep [Phase 3]
A Phase 3 trial of izokibep for hidradenitis suppurativa was terminated, with results posted in October 2025.
-
CLINICAL_TRIALS trial_result · 2025-10-07Clinical Trial Update: Hidradenitis Suppurativa Wound Care [Phase 2]
Phase 2 clinical trial evaluating hidradenitis suppurativa wound care has completed and results have been posted. Sponsor: Wake Forest Unive…
-
CLINICAL_TRIALS other · 2025-09-23Clinical Trial Update: A Study of LAD191 in Adults With Hidradenitis Suppurativa [Phase 2]
This is a Phase 2 clinical trial evaluating LAD191 for hidradenitis suppurativa. The study status is not yet recruiting.
-
CLINICAL_TRIALS trial_result · 2025-09-22Clinical Trial Update: A Study to Evaluate the Efficacy and Safety of Imsidolimab (ANB019) in the Treatment of Participants With Hidradenitis Suppurativa [Phase 2]
Phase 2 clinical trial evaluating the efficacy and safety of imsidolimab (ANB019) for hidradenitis suppurativa; the study has completed and …
-
CLINICAL_TRIALS research · 2025-09-22Clinical Trial Update: Physical Activity in Hidradenitis Suppurativa (HS) [NA]
A University of Miami-sponsored clinical trial is examining the impact of physical activity on hidradenitis suppurativa and is currently rec…
-
CLINICAL_TRIALS research · 2025-09-17Clinical Trial Update: 1726-nm Laser for Acne Inversa (Hidradenitis Suppurativa) [Phase 1]
Phase 1 clinical trial evaluating a 1726-nm laser for hidradenitis suppurativa is currently recruiting.
-
CLINICAL_TRIALS research · 2025-09-15Clinical Trial Update: Botulinum Toxin Therapy in Hidradenitis Suppurativa
This clinical trial update reports that a study evaluating botulinum toxin therapy for hidradenitis suppurativa is currently recruiting.
-
CLINICAL_TRIALS research · 2025-09-05Clinical Trial Update: Constitution of a Prospective Cohort of Patients With Acute Suppurative Hidrosadenitis Followed in the Great West: the COVER Cohort (Verneuil Cohort)
A prospective cohort study (COVER) enrolling patients with hidradenitis suppurativa, conducted at Nantes University Hospital, currently recr…